Siddiqa Ayesha, Zubair Muhammad, Bilal Muhammad, Rasool Nasir, Qamar Muhammad Usman, Khalid Aqsa, Ahmad Gulraiz, Imran Muhammad, Mahmood Sajid, Ashraf Ghulam Abbas
Department of Chemistry, Government College, University Faisalabad, Faisalabad 38000, Pakistan.
Department of Microbiology, Faculty of Life Sciences, Government College, University Faisalabad, Faisalabad 38000, Pakistan.
Pharmaceuticals (Basel). 2022 Jul 8;15(7):841. doi: 10.3390/ph15070841.
-(4-bromophenyl)furan-2-carboxamide () was synthesized by the reaction furan-2-carbonyl chloride () and 4-bromoaniline () in the presence of EtN in excellent yields of 94%. The carboxamide () was arylated by employing triphenylphosphine palladium as a catalyst and KPO as a base to afford -(4-bromophenyl)furan-2-carboxamide analogues () in moderate to good yields (43-83%). Furthermore, we investigated the in vitro anti-bacterial activities of the respective compounds against clinically isolated drug-resistant bacteria , , and . The molecule () was found to be the most effective activity against these bacteria, particularly NDM-positive bacteria as compared to various commercially available drugs. Docking studies and MD simulations further validated it, expressing the active site and molecular interaction stability.
-(4-溴苯基)呋喃-2-甲酰胺()通过呋喃-2-羰基氯()与4-溴苯胺()在EtN存在下反应合成,产率高达94%。通过使用三苯基膦钯作为催化剂和KPO作为碱对羧酰胺()进行芳基化反应,以中等至良好的产率(43-83%)得到-(4-溴苯基)呋喃-2-甲酰胺类似物()。此外,我们研究了各化合物对临床分离的耐药菌、、和的体外抗菌活性。发现分子()对这些细菌,特别是与各种市售药物相比的NDM阳性细菌具有最有效的活性。对接研究和分子动力学模拟进一步验证了这一点,表明了活性位点和分子相互作用稳定性。